Myasthenia Gravis Treatment Market Will Experience Growth, Reaching US$4.1 Billion by the End of 2030, Predicts Persistence Market Research
January 23, 2024 01:45 ET
|
Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Myasthenia Gravis Treatment Market Poised for Steady Growth, driven by Innovation and Rising Awareness The global market for myasthenia gravis (MG)...
Autoimmune Disease Diagnostics Market Surges at 3.8% CAGR from 2019 to 2027 Fueled by Heightened Public Awareness: TMR Report
September 22, 2023 10:36 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018. It is anticipated to...
Human Microbiome Market Growth Analysis – Reach $2921 Million by 2028 at 22.2% CAGR – Global Report 2021-2028 by The Insight Partners
March 21, 2023 10:28 ET
|
The Insight Partners
New York, March 21, 2023 (GLOBE NEWSWIRE) -- The Insight Partners, “Human Microbiome Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in Primary Immune Thrombocytopenia
November 11, 2021 07:30 ET
|
Zai Lab Limited
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), is a patient-focused, innovative, commercial-stage, global...
Nemysis Ltd. Appoints Dr. David S. Sanders to Its Scientific Advisory Board
September 27, 2021 04:30 ET
|
Nemysis Limited
DUBLIN, Sept. 27, 2021 (GLOBE NEWSWIRE) -- David Sanders, MD, is a professor of Gastroenterology and a Consultant Gastroenterologist at the Royal Hallamshire Hospital & the University of...
InveniAI Announces Successful Completion of Milestone in its Collaboration with PRISM BioLab Focused on Designing Novel Inflammasome-Targeted Therapeutic Candidates
July 20, 2021 08:10 ET
|
InveniAI LLC
- Successful generation of INVA8003, a peptidomimetic inhibitor of PYCARD (often referred to as ASC, apoptosis-associated speck-like protein containing CARD) triggers milestone payment to PRISM BioLab...
argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China
January 06, 2021 16:01 ET
|
Zai Lab Limited; argenx
Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more rapidly advance new potential indications into clinical development each yearZai Lab granted...
Trivedi Global, Inc. and Sakina Ansari-Wilson Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical for Decreasing Inflammation and Autoimmune Disorders
May 28, 2019 13:00 ET
|
Trivedi Global, Inc.
Silver Spring, Maryland, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Sakina A. Ansari-Wilson, an evidence-based energy healer, today announces research based on the impact of a biofield energy treated...
Trivedi Global, Inc. in Association with Sakina Ansari-Wilson Announces Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Reduce Inflammation and Autoimmune Disorders
May 28, 2019 12:21 ET
|
Trivedi Global, Inc.
Silver Spring, Maryland, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Sakina A. Ansari-Wilson, an evidence-based healer, today announces research results on the significant impact of a proprietary biofield...
Trivedi Global, Inc. and Maire Mayne Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Combat Inflammation and Autoimmune Disorders
July 13, 2018 09:00 ET
|
Trivedi Global, Inc.
London, United Kingdom, July 13, 2018 (GLOBE NEWSWIRE) -- Maire Mayne, an evidence-based energy healer, today announces research results on the impact of a biofield energy treated nutraceutical to...